Please login to the form below

Not currently logged in
Email:
Password:

Shire adds Sara Mathew to board of directors

Comes as firm aims to become global biotechnology leader
Shire Sara Mathew

Shire has appointed Sara Mathew to its board of directors as a non-executive director.

Mathew who has previously served as chairman, president and CEO of Dun & Bradstreet will also be a member of the audit, compliance and risk committee of the Shire board.

During her 12-year tenure at Dun & Bradstreet she helped transform the company from being a data provider to an innovative digital enterprise that leverages big data, insights and analytics.

In 2013, Mathew was named the top value creator in the S&P 500 by Chief Executive magazine.

Susan Kilsby, chairman at Shire, said: “Sara is a highly-skilled global leader who has demonstrated success in driving strategy and transformation to deliver value for stakeholders.

“Sara also understands first-hand the power of disruptive technologies to substantially influence business in the future, an emerging dynamic in healthcare.

“I am confident that Sara's unique combination of skills and experience will further enrich the Shire Board of Directors as we advance towards becoming a global biotechnology leader.”

8th September 2015

From: Research, Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Streaming Well

Streaming Well is a healthcare focused, award-winning video production company which operates in the US and Europe....

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics